Acute Liver Failure

Acute liver failure refers to sudden, severe liver dysfunction with hepatic encephalopathy in a person without preexisting liver disease. It is most commonly caused by a hepatitis virus or drugs (e.g., acetaminophen).

Quick Answer

What it is

Acute liver failure refers to sudden, severe liver dysfunction with hepatic encephalopathy in a person without preexisting liver disease. It is most commonly caused by a hepatitis virus or drugs (e.g., acetaminophen).

Key findings

  • Grade C: Liver Damage Risk (Felty Germander)
  • Grade D: All-Cause Mortality (N-Acetylcysteine)
  • Grade N/A: Length of hospitalization (N-Acetylcysteine)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

โ„น๏ธ Quick Facts

Quick Facts: Acute Liver Failure

  • Supplements Studied:1
  • Total Participants:469
  • Top Supplement:Felty Germander (C)
469 ppts
1 supps ยท 2 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

Hospital protocol for overdose; oral 600-1200mg daily for general liver support (not for acute ALF)

Standard treatment for acetaminophen overdose; may have benefit in non-acetaminophen ALF via antioxidant effects

15 studies | 1,000 participants

Supporting Stack (Tier 2)

Hospital protocol based on clinical status

May help with hepatic encephalopathy and muscle wasting in liver disease; hospital use

10 studies | 500 participants
5-10mg IV or oral as directed by medical team

Supports clotting factor synthesis; given to address coagulopathy in liver failure

8 studies | 400 participants
50mg daily

Often deficient in liver disease; supplementation may help with encephalopathy

6 studies | 300 participants
Hospital protocol based on serum levels

Hypophosphatemia common during liver regeneration; repletion essential

6 studies | 300 participants
100-200mg IV before glucose in hospital setting

Essential to prevent Wernicke encephalopathy, especially with glucose administration

5 studies | 200 participants

How It Works

Acute liver failure (ALF) is a medical emergency where the liver rapidly loses function in someone without prior liver disease. It can cause confusion (hepatic encephalopathy), bleeding problems, and multi-organ failure. Causes include acetaminophen (Tylenol) overdose (most common in the US/UK), viral hepatitis, drug reactions, toxins, and other conditions. ALF requires immediate hospitalization and often liver transplant.

CRITICAL: ACUTE LIVER FAILURE IS A MEDICAL EMERGENCY. If you or someone has signs of ALF (confusion, jaundice, bleeding, severe fatigue after taking potentially toxic substances), call emergency services immediately. This condition requires ICU care and potentially liver transplant. The supplements listed here are used in hospital settings under medical supervision - this is NOT a home treatment guide.

* N-Acetylcysteine (NAC) is the standard treatment for acetaminophen overdose and is given in hospitals. It works by replenishing glutathione, the liver's main antioxidant. Even in non-acetaminophen ALF, NAC has shown benefit in studies and is often used. This is administered IV in emergency settings.

* Branched-Chain Amino Acids (BCAAs) may help with hepatic encephalopathy (brain fog/confusion from liver failure) and are used in hospital nutrition protocols.

* Vitamin K is given because the failing liver cannot make clotting factors, leading to dangerous bleeding risk. IV or oral vitamin K supports whatever liver function remains.

* Zinc deficiency is common in liver disease and may contribute to encephalopathy. Supplementation may provide some benefit.

* Phosphorus becomes depleted during liver regeneration. Hospitals monitor and replete phosphorus levels as the liver heals.

* Thiamine is given to prevent Wernicke encephalopathy, especially before glucose administration. This is standard ICU practice.

Expected timeline: ALF treatment is measured in hours to days. NAC must be started as early as possible for acetaminophen overdose. Recovery depends on cause, severity, and whether transplant is needed. This is intensive hospital care, not outpatient supplement use.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

C
Liver Damage Risk
Multiple human case reports document acute hepatitis, liver failure, and fatalities following germander ingestion. Neo-clerodane diterpenoids are metabolized by CYP3A4 to reactive compounds that deplete hepatic glutathione and cause hepatocyte damage. These findings led to product bans in France (1992) and FDA warnings.
10 studies
largeโ†‘Worsens
D
All-Cause Mortality
No effect
4 studies
none
?
Length of hospitalization
2 studies
โ†“Improves

Research Citations (34)

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals
PMID: 16449100
The administration of N-acetylcysteine reduces oxidative stress and regulates glutathione metabolism in the blood cells of workers exposed to lead
PMID: 23731375
N-Acetylcysteine Attenuates Fatigue Following Repeated-Bouts of Intermittent Exercise: Practical Implications for Tournament Situations
PMID: 21896942
N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study
PMID: 19581567
New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine
PMID: 16204787
Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factors
PMID: 10778915
N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial
PMID: 23131885
Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
PMID: 34237968
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
PMID: 15866309
Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD
PMID: 15607126

Related Conditions

Trichotillomania (Hair Pulling)

1 shared supplement ยท 4 outcomes

Trichotillomania is the compulsion to pull out one's hair.

Tobacco Use Disorder

1 shared supplement ยท 2 outcomes

Tobacco use disorder is a condition involving a dependence on the use of nicotine-containing tobacco products like cigarettes. It involves compulsive cravings for tobacco and cessation of use is very difficult.

Surgical Recovery

1 shared supplement ยท 43 outcomes

Surgical recovery refers to physiological endpoints after surgery including recovery time and adverse events including morbidity and mortality, as well as the presence of physical pain, physical comfort with everyday activities, physical independence, psychological support, and emotional well-being.

Substance Use Disorder

1 shared supplement ยท 2 outcomes

Substance use disorder is an abnormal mental condition characterized by an inability to control the use of legal or illegal drugs, alcohol, or medications, leading to health issues or problems at work or home.

Soccer Performance

1 shared supplement ยท 45 outcomes

Soccer performance refers to skills that relate to success in the sport of soccer (football) including dribbling, passing, juggling, shooting, bending, turning, goalkeeping, agility, speed, and stamina.

Schizophrenia

1 shared supplement ยท 69 outcomes

Schizophrenia is a brain condition that may cause auditory and/or visual hallucinations, delusions, difficulties with emotions and cognition, and verbal communication problems. These symptoms manifest between the ages of 16 and 30.

Polycystic Ovary Syndrome (PCOS)

1 shared supplement ยท 220 outcomes

Polycystic ovary syndrome (PCOS) is a hormone disorder that is common among women of reproductive age. PCOS is often caused by high androgen levels and frequently involves infertility, cysts on the ovaries, and metabolic abnormalities.

Overweight

1 shared supplement ยท 379 outcomes

Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).